Grebely J - Search Results

1

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.

Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, Popping S, Sfalcin JA, Parczewski M, Sarrazin C, de Salazar A, Fuentes A, Sayan M, Quer J, Kjellin M, Kileng H, Mor O, Lennerstrand J, Fourati S, Di Maio VC, Chulanov V, Pawlotsky JM, Harrigan PR, Ceccherini-Silberstein F, Garcia F; SHARED Collaborators. Howe AYM, et al. Among authors: grebely j. JHEP Rep. 2022 Feb 24;4(5):100462. doi: 10.1016/j.jhepr.2022.100462. eCollection 2022 May. JHEP Rep. 2022. PMID: 35434589 Free PMC article.

2

The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.

Matthews GV, Grebely J, Dore GJ. Matthews GV, et al. Among authors: grebely j. J Hepatol. 2008 Sep;49(3):305-7. doi: 10.1016/j.jhep.2008.06.005. Epub 2008 Jun 26. J Hepatol. 2008. PMID: 18644647 Free article. No abstract available.

3

HCV reinfection studies and the door to vaccine development.

Grebely J, Thomas DL, Dore GJ. Grebely J, et al. J Hepatol. 2009 Oct;51(4):628-31. doi: 10.1016/j.jhep.2009.07.002. Epub 2009 Jul 17. J Hepatol. 2009. PMID: 19660823 Free article. No abstract available.

4

Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.

Grebely J, Matthews GV, Petoumenos K, Dore GJ. Grebely J, et al. J Viral Hepat. 2010 Dec;17(12):896. doi: 10.1111/j.1365-2893.2009.01256.x. J Viral Hepat. 2010. PMID: 20051007 No abstract available.

5

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.

Grebely J, Raffa JD, Lai C, Kerr T, Fischer B, Krajden M, Dore GJ, Tyndall MW. Grebely J, et al. J Viral Hepat. 2011 Jan;18(1):32-41. doi: 10.1111/j.1365-2893.2010.01279.x. J Viral Hepat. 2011. PMID: 20196806

6

Reinfection with hepatitis C virus following sustained virological response in injection drug users.

Grebely J, Knight E, Ngai T, Genoway KA, Raffa JD, Storms M, Gallagher L, Krajden M, Dore GJ, Duncan F, Conway B. Grebely J, et al. J Gastroenterol Hepatol. 2010 Jul;25(7):1281-4. doi: 10.1111/j.1440-1746.2010.06238.x. J Gastroenterol Hepatol. 2010. PMID: 20594256

7

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.

Grebely J, Bryant J, Hull P, Hopwood M, Lavis Y, Dore GJ, Treloar C. Grebely J, et al. J Viral Hepat. 2011 Apr;18(4):e104-16. doi: 10.1111/j.1365-2893.2010.01370.x. Epub 2010 Sep 14. J Viral Hepat. 2011. PMID: 20840350

8

Hepatitis C: Enhancing treatment for hepatitis C among drug users.

Grebely J, Dore GJ. Grebely J, et al. Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):11-3. doi: 10.1038/nrgastro.2010.186. Epub 2010 Nov 30. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21119610 No abstract available.

9

Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.

Grebely J, Dore GJ. Grebely J, et al. J Infect Dis. 2011 Mar 1;203(5):571-4. doi: 10.1093/infdis/jiq111. Epub 2011 Jan 31. J Infect Dis. 2011. PMID: 21282190 Free PMC article. No abstract available.

10

Treatment of acute HCV infection.

Grebely J, Matthews GV, Dore GJ. Grebely J, et al. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):265-74. doi: 10.1038/nrgastro.2011.32. Epub 2011 Mar 22. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21423258 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters